Report cover image

Global Synthetic Blood Substitutes and Blood Product Market 2025–2034

Published Nov 01, 2025
SKU # CSTM20669742

Description

Synthetic Blood Substitutes and Blood Product Market Size, Trends and Insights By Source (Human Blood, Animal Blood, Synthetic Polymers, Stem Cells, Others), By Type (Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander), By Installation Type (Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Others), By End-User (Hospitals and Clinics, Blood Banks, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034

Table of Contents

Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research Methodology
1.3.1 Market Research Type
1.3.2 Market Research Methodology
Chapter 2. Executive Summary
2.1 Global Synthetic Blood Substitutes and Blood Product Market (2025 – 2034) (USD Million)
2.2 Global Synthetic Blood Substitutes and Blood Product Market: snapshot
Chapter 3. Global Synthetic Blood Substitutes and Blood Product Market – Industry Analysis
3.1 Synthetic Blood Substitutes and Blood Product Market: Market Dynamics
3.2 Market Drivers
3.2.1 Rising Awareness of the Benefits of Artificial Blood
3.2.2 Increasing Use of Blood Substitutes in Organ Transplantation
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porters Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Source
3.7.2 Market Attractiveness Analysis By Type
3.7.3 Market Attractiveness Analysis By Installation Type
3.7.4 Market Attractiveness Analysis By End-User
Chapter 4. Global Synthetic Blood Substitutes and Blood Product Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Synthetic Blood Substitutes and Blood Product Market: Company Market Share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, collaboration, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Synthetic Blood Substitutes and Blood Product Market – Source Analysis
5.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Source
5.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Source, 2024 and 2034
5.2 Human Blood
5.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Human Blood, 2025 – 2034 (USD Million)
5.3 Animal Blood
5.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Animal Blood, 2025 – 2034 (USD Million)
5.4 Synthetic Polymers
5.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Synthetic Polymers, 2025 – 2034 (USD Million)
5.5 Stem Cells
5.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Stem Cells, 2025 – 2034 (USD Million)
5.6 Others
5.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
Chapter 6. Global Synthetic Blood Substitutes and Blood Product Market – Type Analysis
6.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Type
6.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Type, 2024 and 2034
6.2 Perfluorocarbon Based Product (PFC)
6.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Perfluorocarbon Based Product (PFC), 2025 – 2034 (USD Million)
6.3 Haemoglobin Based Oxygen Carrier
6.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Haemoglobin Based Oxygen Carrier, 2025 – 2034 (USD Million)
6.4 Synthetic Platelet
6.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Synthetic Platelet, 2025 – 2034 (USD Million)
6.5 Recombinant Factor
6.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Recombinant Factor, 2025 – 2034 (USD Million)
6.6 Blood Expander
6.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Blood Expander, 2025 – 2034 (USD Million)
Chapter 7. Global Synthetic Blood Substitutes and Blood Product Market – Installation Type Analysis
7.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Installation Type
7.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Installation Type, 2024 and 2034
7.2 Cardiovascular Diseases
7.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Cardiovascular Diseases, 2025 – 2034 (USD Million)
7.3 Anaemia
7.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Anaemia, 2025 – 2034 (USD Million)
7.4 Organ Transplant
7.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Organ Transplant, 2025 – 2034 (USD Million)
7.5 Injury and Trauma
7.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Injury and Trauma, 2025 – 2034 (USD Million)
7.6 Others
7.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
Chapter 8. Global Synthetic Blood Substitutes and Blood Product Market – End-User Analysis
8.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By End-User
8.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By End-User, 2024 and 2034
8.2 Hospitals and Clinics
8.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Hospitals and Clinics, 2025 – 2034 (USD Million)
8.3 Blood Banks
8.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Blood Banks, 2025 – 2034 (USD Million)
8.4 Others
8.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
Chapter 9. Synthetic Blood Substitutes and Blood Products Market Regional Analysis
9.1 Global Synthetic Blood Substitutes and Blood Products Market Regional Overview
9.2 Global Synthetic Blood Substitutes and Blood Products Market Share by Region, 2024 & 2034 (USD Million)
9.3. North America
9.3.1 North America Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
9.3.1.1 North America Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
9.4 North America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
9.4.1 North America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
9.5 North America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
9.5.1 North America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
9.6 North America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
9.6.1 North America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
9.7 North America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
9.7.1 North America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
9.8. Europe
9.8.1 Europe Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
9.8.1.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
9.9 Europe Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
9.9.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
9.10 Europe Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
9.10.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
9.11 Europe Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
9.11.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
9.12 Europe Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
9.12.1 Europe Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
9.13. Asia Pacific
9.13.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
9.13.1.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
9.14 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
9.14.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
9.15 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
9.15.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
9.16 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
9.16.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
9.17 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
9.17.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
9.18. Latin America
9.18.1 Latin America Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
9.18.1.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
9.19 Latin America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
9.19.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
9.20 Latin America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
9.20.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
9.21 Latin America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
9.21.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
9.22 Latin America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
9.22.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
9.23. The Middle-East and Africa
9.23.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
9.23.1.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
9.24 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
9.24.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
9.25 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
9.25.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
9.26 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
9.26.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
9.27 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
9.27.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
Chapter 10. Company Profiles
10.1 Aurum Biosciences Ltd
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Business Strategy
10.1.5 Recent Developments
10.2 Baxter International
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Business Strategy
10.2.5 Recent Developments
10.3 Dentritech Inc
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Business Strategy
10.3.5 Recent Developments
10.4 Hemoglobin Oxygen Therapeutics LLC
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Business Strategy
10.4.5 Recent Developments
10.5 HemoBioTech Inc.
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Business Strategy
10.5.5 Recent Developments
10.6 Hemarina SA
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Business Strategy
10.6.5 Recent Developments
10.7 KaloCyte Inc.
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Business Strategy
10.7.5 Recent Developments
10.8 NuvOx Pharma LLC
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Business Strategy
10.8.5 Recent Developments
10.9 SpheriTech Ltd
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Business Strategy
10.9.5 Recent Developments
10.10 HemCon Medical Technologies Inc.
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Business Strategy
10.10.5 Recent Developments
10.11 Matrox Medical Inc.
10.11.1 Overview
10.11.2 Financials
10.11.3 Product Portfolio
10.11.4 Business Strategy
10.11.5 Recent Developments
10.12 Sorrento Therapeutics Inc.
10.12.1 Overview
10.12.2 Financials
10.12.3 Product Portfolio
10.12.4 Business Strategy
10.12.5 Recent Developments
10.13 Xeris Pharmaceuticals Inc.
10.13.1 Overview
10.13.2 Financials
10.13.3 Product Portfolio
10.13.4 Business Strategy
10.13.5 Recent Developments
10.14 BPL Medical Technologies
10.14.1 Overview
10.14.2 Financials
10.14.3 Product Portfolio
10.14.4 Business Strategy
10.14.5 Recent Developments
10.15 Sangart Inc.
10.15.1 Overview
10.15.2 Financials
10.15.3 Product Portfolio
10.15.4 Business Strategy
10.15.5 Recent Developments
10.16 Hemosol Inc.
10.16.1 Overview
10.16.2 Financials
10.16.3 Product Portfolio
10.16.4 Business Strategy
10.16.5 Recent Developments
10.17 Sonaca Group
10.17.1 Overview
10.17.2 Financials
10.17.3 Product Portfolio
10.17.4 Business Strategy
10.17.5 Recent Developments
10.18 The Medicines Company
10.18.1 Overview
10.18.2 Financials
10.18.3 Product Portfolio
10.18.4 Business Strategy
10.18.5 Recent Developments
10.19 Erytech Pharma
10.19.1 Overview
10.19.2 Financials
10.19.3 Product Portfolio
10.19.4 Business Strategy
10.19.5 Recent Developments
10.20 American Red Cross
10.20.1 Overview
10.20.2 Financials
10.20.3 Product Portfolio
10.20.4 Business Strategy
10.20.5 Recent Developments
10.21 Hemerus Medical B.V.
10.21.1 Overview
10.21.2 Financials
10.21.3 Product Portfolio
10.21.4 Business Strategy
10.21.5 Recent Developments
10.22 Others.
10.22.1 Overview
10.22.2 Financials
10.22.3 Product Portfolio
10.22.4 Business Strategy
10.22.5 Recent Developments
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.